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Résumé en
anglais
The delivery of drugs to brain tumors is limited by the presence of the blood-brain
barrier (BBB) separating the blood from the cerebral parenchyma. An
understanding of the specific mechanisms of the brain capillary endothelium has
led to the development of various strategies to enhance the penetration of drugs
into the brain tissue. Active targeting is a non-invasive approach, which consists in
transporting drugs to target organs using site-specific ligands. Drug-loaded
nanocarriers capable of recognizing brain capillary endothelial cells and cerebral
tumoral cells have shown promising potential in oncology. Endogenous and
chimeric ligands binding to carriers or receptors of the BBB have been directly or
indirectly conjugated to nanocarriers. This review indexes the main targeted
colloidal systems used for drug delivery to the brain. Their pharmacological
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